Similar articles

• Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective.

  Jarboe EA, Folkins AK, Drapkin R, Ince TA, Agoston ES, Crum CP. Jarboe EA, et al. Histopathology. 2009 Nov;55(5):619. doi: 10.1111/j.1365-2559.2009.03408.x. Histopathology. 2009. PMID: 19912369 No abstract available.
• Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

  Kindelberger DW, Lee Y, Miron A, Hirsch MS, Feltmate C, Medeiros F, Callahan MJ, Garner EO, Gordon RW, Birch C, Berkowitz RS, Muto MG, Crum CP. Kindelberger DW, et al. Am J Surg Pathol. 2007 Feb;31(2):161-9. doi: 10.1097/01.pas.0000213335.40358.47. Am J Surg Pathol. 2007. PMID: 17255760
• Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study.

  Piek JM, Torrenga B, Hermsen B, Verheijen RH, Zweemer RP, Gille JJ, Kenemans P, van Diest PJ, Menko FH. Piek JM, et al. Fam Cancer. 2003;2(2):73-8. doi: 10.1023/a:1025700807451. Fam Cancer. 2003. PMID: 14574155
• Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.

  Crum CP, Drapkin R, Kindelberger D, Medeiros F, Miron A, Lee Y. Crum CP, et al. Clin Med Res. 2007 Mar;5(1):35-44. doi: 10.3121/cmr.2007.702. Clin Med Res. 2007. PMID: 17456833 Free PMC article. Review.
• The role of the fallopian tube in the origin of ovarian cancer.

  Erickson BK, Conner MG, Landen CN Jr. Erickson BK, et al. Am J Obstet Gynecol. 2013 Nov;209(5):409-14. doi: 10.1016/j.ajog.2013.04.019. Epub 2013 Apr 10. Am J Obstet Gynecol. 2013. PMID: 23583217 Free PMC article. Review.